Scientist.com, Discovery aid liquid biopsy and immunotherapy research

LabPulse.com staff writers
Dec 3, 2020
2020 04 29 22 14 7161 Lab Blood Dropper V2 400

Discovery Life Sciences and outsourced research network provider Scientist.com are joining forces on technology services aiding liquid biopsy and immunotherapy studies.

Through the new offering, Illumina's TruSight Oncology 500 (TSO500) technology for formalin-fixed paraffin-embedded (FFPE) and circulating tumor DNA (ctDNA) services will be made available to Scientist.com users. The TSO500 technology has been incorporated into Discovery's HudsonAlpha Discovery sequencing and bioinformatics laboratory, and is available under one umbrella legal agreement, the companies noted.

Latest in Sequencing
Infectious Diseases Research Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
November 13, 2023
Lab Test Tube Dna Blood Social
Velsera, Solaris Health partner to expand genetic testing access to urology practices
November 8, 2023
Cell Gene Therapy Dna Social
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
November 7, 2023
Blood Test Samples Lab Social
Blood test for biomarker offers route to affordable cancer screening
November 6, 2023
Related Stories
2017 09 14 23 05 1167 Cancer Cell 400
CLIA
Lucence, Waseda University partner on liquid biopsy test
2019 04 27 00 03 6781 Dna Sequence Shadow 400
Guideline
Holy Grail: Ilumina nabs cancer testing firm in $8B deal
2019 07 26 20 46 7792 Lab Blood Woman 400
Infectious
Top 5 facts about the IVD market
2020 01 03 00 14 8701 Illumina 400
Agreement
Illumina unveils megadeal with Roche, new sequencers
More in Sequencing
Illumina launches pricing program for pathogen sequencing tools in LMICs
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Infectious Diseases Research Social
Velsera, Solaris Health partner to expand genetic testing access to urology practices
Healthcare technology company Velsera and urological services platform Solaris Health are collaborating to expand access to genetic testing to cancer patients and their physicians at urology practices affiliated with Solaris.
November 8, 2023
Lab Test Tube Dna Blood Social
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Cell Gene Therapy Dna Social
Blood test for biomarker offers route to affordable cancer screening
Researchers have developed a sensitive blood test for a highly specific biomarker of multiple common tumors, laying the groundwork for a product that could improve cancer screening.
November 6, 2023
Blood Test Samples Lab Social
Oxford Nanopore partners with Fabric Genomics on assessment of genetic disease in children
Oxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.
November 1, 2023
Child Hospital Social
US ambassador visits NGS laboratory in India
There is growing bilateral cooperation in cancer research, prevention, control, and management, where leaders said they looked forward to the launch of the India-U.S. Cancer Dialogue.
October 30, 2023
Dna Genome Gene Targeted Social
Pharma companies back project to create largest African ancestry genomics research database
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Dna Genome Gene Targeted Social
Sanger Institute starts program to make biology as easy to engineer as software
The Wellcome Sanger Institute has begun a research program to empower scientists to engineer biology as easily as software, electronics, and cars.
October 23, 2023
Dna Sequencing Sanger Social
23andMe accused of ‘reckless’ practices as data leak triggers class action lawsuit
23andMe faces a class action lawsuit for allegedly failing to use “adequate and reasonable cyber-security procedures” that could have prevented a data leak.
October 16, 2023
Computer Keyboard Shadow Cyberattack Social
Researchers develop nanopore sequencing method for mapping disease biomarkers
A nanopore sequencing method that can map dozens of biomarkers at the same time has the potential to transform testing for heart disease and other conditions, say researchers.
October 11, 2023
Genome Sequence Barcode Social
Oxford Nanopore collaboration makes classroom DNA sequencing accessible
An ambition to make in-classroom DNA sequencing routinely available, more user-friendly, and more egalitarian in U.S. universities and schools has been set out by a leading genetics educator.
October 9, 2023
Dna Sequencing Data Analysis Social
ACLA warns proposed Medicare criteria will ‘impede’ access to genetic oncology testing
The American Clinical Laboratory Association (ACLA) has warned that draft Medicare coverage criteria “will impede patient access to appropriate genetic testing for oncology.”
October 6, 2023
Lab Test Tube Dna Blood Social
Page 1 of 48
Next Page